Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Tonsillitis II: Management

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors Associated With Menopause Symptoms: A Systematic Review and Meta-Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026

Same author

Response to McLemore et al.'s Letter to the Editor.

Maternal and child health journal·2026

Same author

Factors Associated With Hormone Replacement Therapy Use: A Systematic Review and Meta-Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026

Same author

History of paediatric genetics: 100 years of scientific progress and ethical challenges.

Archives of disease in childhood·2025

Same author

Nurses' Perspectives on AI in Clinical Practice: Implications for Training and Workforce Development.

Nursing administration quarterly·2025

Same author

MCH and Abortion: Towards a Stronger Relationship.

Maternal and child health journal·2025

Search research articles

Related Experiment Video

Updated: Nov 12, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

COVID-19 Management in Pediatrics.

Magalie L Alcindor, FitzGerald Alcindor, Kristy E Richard

The Journal for Nurse Practitioners : JNP

|March 16, 2021

Summary

This article details the management of Coronavirus disease 2019 (COVID-19) in children and adolescents. It covers current understanding, risks, and implications for healthcare providers, focusing on pediatric care during the evolving pandemic.

Keywords:

COVID-19 pandemic diagnosis infectious disease management pediatric nurse practitioner treatment

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

Related Experiment Videos

Last Updated: Nov 12, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

Area of Science:

Pediatric Infectious Diseases
Public Health
Epidemiology

Background:

Coronavirus disease 2019 (COVID-19) is a significant global pandemic.
While vaccines are emerging, disease-specific therapies remain limited.
Children are generally less affected but remain susceptible, especially neonates and those with comorbidities.

Purpose of the Study:

To provide comprehensive COVID-19 management strategies for pediatric populations.
To outline implications for nursing and advanced practice providers in pediatric care.
To address the evolving landscape of the pandemic, including virus mutations and vaccination.

Main Methods:

Review of current scientific literature on COVID-19 in children.
Analysis of epidemiological data and clinical presentations.
Synthesis of guidelines for pediatric COVID-19 management.

Main Results:

COVID-19 severity varies in children, with higher risks for neonates and those with underlying health conditions.
Multisystem inflammatory syndrome in children (MIS-C) is a severe complication.
The pandemic's dynamics are shifting with new variants and increasing vaccination efforts.

Conclusions:

Effective management of COVID-19 in children requires tailored approaches considering age and comorbidities.
Healthcare providers need updated knowledge on pediatric COVID-19, including MIS-C.
Continuous adaptation to the pandemic's evolution is crucial for pediatric care.